Last checked at 27 Dec 2023 17:04
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat1
AZN Share
Trades9,371
AZN
Live RNS1
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
12,170.00
Bid:
12,172.00
Ask:
12,174.00
Change:
108.00 (0.90%)
Spread:
2.00 (0.016%)
Open:
12,194.00
High:
12,266.00
Low:
12,054.00
Prev. Close:
12,062.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Consort Medical signs agreement with AstraZeneca
Wed, 07th Sep 2016 08:43
(ShareCast News) - Consort medical, a provider of advanced technology for drugs, has signed a new contract with pharmaceutical giant AstraZeneca for the supply of its Bespak respiratory devices.AstraZeneca and Bespak have agreed to enter into a multi-year agreement for the scale-up and supply of Bespak's proprietary pressurized metered dose inhaler (pMDI) valves and actuators.These inhalers are used for the long-term maintenance treatment of patients suffering from chronic obstructive pulmonary disease (COPD), chronic bronchitis and emphysema.Chief executive Jon Glenn said: "We are delighted to have successfully concluded this agreement with AstraZeneca. This further reinforces the ongoing strength of our respiratory device franchise in the pMDI segment."The group continues to trade in line with the board's expectations of the current financial year on a constant currency basis, the company said in a statement.Regarding the impact from Brexit, the firm said it does not expect any 'fundamental' changes on the group's businesses. According to the board Bespak and Aesica have "a strong pedigree of providing excellent services to their international customer base and will continue to do so as the UK prepares to exit the EU, and thereafter".Consort had benefitted from the depreciation of sterling as its foreign exchange exposure is mainly in Euro. Transactional foreign exchange effects are also expected to be limited in the current year due to the firm's protective forward currency hedging contract.Shares rose 1.29% to 1051.36p at 1008 BST on Wednesday.
More News
27 Dec 2023 17:02
LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close
(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.
Read more27 Dec 2023 14:25
London close: Stocks maintain gains amid post-Christmas rally
(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.
Read more27 Dec 2023 12:06
LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes
(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.
Read more27 Dec 2023 11:20
London midday: Stocks ride global wave of post-Christmas optimism
(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.
Read more27 Dec 2023 08:48
LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials
(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.
Read more27 Dec 2023 08:26
London open: FTSE takes cues from Wall Street 'Santa rally'
(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.
Read more27 Dec 2023 08:24
TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline
(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.
Read more27 Dec 2023 07:52
LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns
(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.
Read more27 Dec 2023 07:02
AstraZeneca to buy Gracell Technologies for $1.2bn
(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.
Read more26 Dec 2023 21:26
Wall Street ends higher in final stretch of 2023, rate cuts in view
Intel up on $3.2 bln grant from Israel
*Read more26 Dec 2023 21:00
Wall Street ends higher in final stretch of 2023, rate cuts in view
Intel up on $3.2 bln grant from Israel
*Read more26 Dec 2023 19:41
Wall Street gains on final stretch of 2023, rate cuts in view
Intel up on $3.2 bln grant from Israel
*Read more22 Dec 2023 08:47
AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"
(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.
Read more22 Dec 2023 07:50
LONDON BRIEFING: UK on brink of recession as economy contracts in Q3
(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.
Read more